Cargando…
Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review
SET-CAN/NUP214 fusion is a recurrent event most commonly seen in T-cell acute lymphoblastic leukemia (T-ALL). It is related to resistance to glucocorticoids and chemotherapy; however, the reported prognosis of T-ALL with SET-CAN/NUP214 fusion is diverse, and the optimal treatment option remains unde...
Autores principales: | Lin, Na, Liu, Zhenghua, Li, Yan, Yan, Xiaojing, Wang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044795/ https://www.ncbi.nlm.nih.gov/pubmed/33869055 http://dx.doi.org/10.3389/fonc.2021.651494 |
Ejemplares similares
-
SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances
por: Song, Jingyu, et al.
Publicado: (2023) -
The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation
por: Shen, Yuyan, et al.
Publicado: (2023) -
SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines
por: Quentmeier, Hilmar, et al.
Publicado: (2009) -
NUP214 fusion genes in acute leukemia (Review)
por: ZHOU, MIN-HANG, et al.
Publicado: (2014) -
SET-NUP214 Fusion Gene Involved Early T-Cell Precursor Acute Lymphoblastic Leukemia in Adult with B Marker Expression
por: Xu, Xiaoying, et al.
Publicado: (2021)